CSTE Caesarstone Ltd. Annual reports only
Cut Stone & Stone Products · Nasdaq · SEC CIK 1504379
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-10.4%
TTM net income YoY-220.9%
TTM EPS YoY-252.2%
Revenue 3-yr CAGR-16.8%
Net income 3-yr CAGR—
Margins
Gross margin18.4%
Operating margin-31.6%
Net margin-34.6%
FCF margin-11.8%
EBITDA margin-28.1%
Returns
ROE-66.9%
ROA-29.0%
ROIC (approx.)-46.6%
Asset turnover0.84x
Leverage & solvency
Liabilities / assets65.1%
Debt / equity0.00x
Current ratio1.83x
Interest coverage-1,821.87x
Cash quality & payout
Operating cash flow / net income0.28x
Accruals ratio-21.0%
Payout ratio—
Capex / revenue2.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $397.23M | $443.22M |
| Cost of revenue | $323.95M | $346.55M |
| Gross profit | $73.28M | $96.67M |
| R&D expense | $5.67M | $4.95M |
| SG&A expense | $39.49M | $39.12M |
| Operating income | -$125.71M | -$41.89M |
| Interest expense | $69,000 | $300,000 |
| Pretax income | -$133.47M | -$41.90M |
| Income tax | $4.28M | $1.08M |
| Net income | -$137.47M | -$42.83M |
| EBITDA | -$111.51M | -$24.75M |
| EPS (basic) | -3.98 | -1.13 |
| EPS (diluted) | -3.98 | -1.13 |
| Weighted avg. shares (diluted) | 34.57M | 34.54M |
| Balance sheet | ||
| Cash & equivalents | $58.44M | $57.34M |
| Receivables | $48.29M | $46.88M |
| Inventory | $94.28M | $112.61M |
| Current assets | $253.09M | $348.48M |
| PP&E, net | $30.15M | $75.72M |
| Goodwill | — | $0 |
| Intangibles | $0 | $263,000 |
| Total assets | $398.44M | $549.04M |
| Current liabilities | $138.17M | $151.69M |
| Short-term debt | $26.92M | $24.34M |
| Long-term debt | — | $107.31M |
| Total debt | — | $131.65M |
| Total liabilities | $259.23M | $275.26M |
| Shareholders' equity | $139.21M | $271.58M |
| Net debt | — | $74.32M |
| Shares outstanding | 34.57M | 34.55M |
| Cash flow statement | ||
| Operating cash flow | -$38.03M | $31.87M |
| Capital expenditure | $9.04M | $10.42M |
| Free cash flow | -$47.06M | $21.45M |
| Investing cash flow | $41.98M | -$24.36M |
| Financing cash flow | -$3.88M | -$3.04M |
| Depreciation & amortization | $14.20M | $17.13M |
| Stock-based compensation | $1.20M | $2.04M |
| Dividends paid | — | $0 |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.